查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球皰疹感染治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測
市場調查報告書
商品編碼
1305154

全球皰疹感染治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global Herpes Infection Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 400 Pages | 商品交期: 最快1-2個工作天內

價格

皰疹感染是指由單純皰疹病毒（HSV）引起的感染。皰疹感染的症狀包括核心潰瘍和發熱水皰。可以通過物理治療、體液採樣和血液檢查等方法進行診斷。目前，皰疹感染無法治愈，但有一些藥物有助於減輕症狀、緩解疼痛和防止病毒傳播。這些藥物包括泛昔洛韋、阿昔洛韋和伐昔洛韋。

市場動態：

造成皰疹感染治療市場需求的主要因素是糖尿病和高血壓等疾病患病率的上升。醫院感染的增加以及發展中國家衛生習慣的缺乏正在推動這一市場的需求。市場上的主要企業正致力於擴大產品組合，滿足對簡易治療方案的高需求。研發活動的不斷成長，以及對口唇皰疹和生殖器皰疹抗病毒藥物開發的日益重視，正在擴大這一市場的需求。醫療保健行業投資的成長和新產品的推出正在擴大該市場的需求。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構，評估全球競爭吸引力。此外，這些工具還對全球皰疹感染治療市場的各個細分市場進行了全面評估。皰疹感染治療行業的成長和趨勢為本研究提供了全面的方法。

市場細分：

皰疹感染治療市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 治療
  • 疫苗

按類型

  • 單純皰疹（單純皰疹1型、單純皰疹2型）
  • 帶狀皰疹

按藥物分類

  • 阿昔洛韋
  • 伐昔洛韋
  • 泛昔洛韋
  • 其他藥物

按給藥途徑

  • 口服
  • 局部用藥
  • 注射劑

按皰疹病毒疫苗分類

  • 單純皰疹
  • 帶狀皰疹

按銷售管道

  • 醫院藥房
  • 零售藥店
  • 網上藥店

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區皰疹感染治療市場的當前和未來需求。此外，報告還重點關注了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。皰疹感染治療市場的主要參與者包括Teva Pharmaceutical Industries Ltd.、雅培、葛蘭素史克公司、Cipla Inc.、禮來公司、默克公司、諾華公司、GlaxoSmithKline plc、Cipla Inc.Inc.、Novartis AG、F. Hoffmann-La Roche Ltd.、Teva Pharmaceutical Industries Ltd.等。本節包括競爭格局的整體觀點，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

目 錄

第一章：前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章：執行摘要

  • 市場亮點
  • 全球市場概況

第三章：皰疹感染治療-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按藥物分類的市場吸引力分析
    • 按給藥途徑的市場吸引力分析
    • 按皰疹病毒疫苗市場吸引力分析
    • 按銷售管道市場吸引力分析
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章：covid-19爆發的影響分析

第六章：全球皰疹感染治療市場分析：按產品分類

  • 產品概述
  • 歷史和預測數據
  • 產品分析
  • 治療藥物
  • 疫苗

第七章：全球皰疹感染治療市場分析：按類型分類

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 單純皰疹（單純皰疹1，單純皰疹2）
  • 帶狀皰疹

第八章：全球皰疹感染治療市場分析：按藥物分類

  • 按藥物分類概述
  • 歷史和預測數據
  • 按藥物分析
  • 阿昔洛韋
  • 伐昔洛韋
  • 泛昔洛韋
  • 其他藥物

第九章：全球皰疹感染治療市場分析：按給藥途徑分類

  • 給藥途徑概述
  • 歷史和預測數據
  • 按給藥途徑分析
  • 口服
  • 局部用藥
  • 注射劑

第10章：全球皰疹感染治療市場分析：按皰疹疫苗分類

  • 皰疹病毒疫苗概述
  • 歷史和預測數據
  • 皰疹病毒疫苗分析
  • 單純皰疹
  • 帶狀皰疹

第十一章：全球皰疹感染治療市場分析：按配銷通路分類

  • 配銷通路概述
  • 歷史和預測數據
  • 按銷售管道分析
  • 醫院藥房
  • 零售藥店
  • 網上藥店

第十二章：全球皰疹感染治療市場銷售分析：按地區分類

  • 地區展望
  • 地區介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美地區銷售分析
    • 北美地區各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區各細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲各細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東及非洲其他地區銷售分析

第十三章：皰疹感染治療企業競爭格局

  • 皰疹感染治療市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第十四章: 公司概況

  • 頂級公司佔有率分析
  • 市場集中度
  • Teva Pharmaceutical Industries Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Abbott
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • GlaxoSmithKline plc
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Cipla Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Eli Lilly and Company
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Merck & Co. Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Novartis AG
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • F. Hoffmann-La Roche Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

*注：在公司概況中，財務細節和近期發展取決於可用性，如果是私營公司則可能不包括在內。

Product Code: VMR112110564

Herpes infection refers to the infection caused by the herpes simplex virus (HSV). The symptoms of herpes infection include core sores and fever blister. It can be diagnosed with the help of physical treatment, fluid sampling as well as blood tests etc. Currently, herpes infection is not curable, but there are some medications that help reduce the symptoms, relieve pain and prevent the transmission of the virus. The medications include famciclovir, acyclovir and valacyclovir. 

Market Dynamics:

The main factor responsible for the demand for herpes infection treatment market is the increasing prevalence of diseases such as diabetes and hypertension.The rise in the low immunity aliment population and a growing number of people suffering chronic diseases are contributing to the demand for this market. An increase in hospital-acquired infections coupled with a lack of sanitary practices in developing countries is surging the demand for this market. Major players in the market are focusing on the expansion of product portfolios and meeting the high demand for improvised treatment options. Growing research and development activities, along with increasing emphasis on developing antiviral medications for orolabial and genital herpes, are expanding the demand for this market. Growing investment in the healthcare sector and the launch of new products is augmenting the demand for this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of herpes infection treatment. The growth and trends of herpes infection treatment industry provide a holistic approach to this study. 

Market Segmentation:

This section of the herpes infection treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product

  • Therapeutics
  • Vaccine

By Type

  • Herpes Simplex (Herpes Simplex 1, Herpes Simplex 2)
  • Herpes Zoster

By Drug

  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Others

By Route Of Administration

  • Oral
  • Topical
  • Injection

By Herpes Vaccine

  • Herpes Simplex
  • Herpes Zoster

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Herpes Infection Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the herpes infection treatment market include Teva Pharmaceutical Industries Ltd., Abbott, GlaxoSmithKline plc, Cipla Inc., Eli Lilly and Company, Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HERPES INFECTION TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Drug
    • 3.7.4 Market Attractiveness Analysis By Route Of Administration
    • 3.7.5 Market Attractiveness Analysis By Herpes Vaccine
    • 3.7.6 Market Attractiveness Analysis By Distribution Channel
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HERPES INFECTION TREATMENT MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Therapeutics Historic and Forecast Sales by Regions
  • 6.5 Vaccine Historic and Forecast Sales by Regions

7 . GLOBAL HERPES INFECTION TREATMENT MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 Herpes Simplex (Herpes Simplex 1, Herpes Simplex 2) Historic and Forecast Sales by Regions
  • 7.5 Herpes Zoster Historic and Forecast Sales by Regions

8 . GLOBAL HERPES INFECTION TREATMENT MARKET ANALYSIS BY DRUG

  • 8.1 Overview by Drug
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Drug
  • 8.4 Acyclovir Historic and Forecast Sales by Regions
  • 8.5 Valacyclovir Historic and Forecast Sales by Regions
  • 8.6 Famciclovir Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL HERPES INFECTION TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 9.1 Overview by Route Of Administration
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Route Of Administration
  • 9.4 Oral Historic and Forecast Sales by Regions
  • 9.5 Topical Historic and Forecast Sales by Regions
  • 9.6 Injection Historic and Forecast Sales by Regions

10 . GLOBAL HERPES INFECTION TREATMENT MARKET ANALYSIS BY HERPES VACCINE

  • 10.1 Overview by Herpes Vaccine
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Herpes Vaccine
  • 10.4 Herpes Simplex Historic and Forecast Sales by Regions
  • 10.5 Herpes Zoster Historic and Forecast Sales by Regions

11 . GLOBAL HERPES INFECTION TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 11.1 Overview by Distribution Channel
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Distribution Channel
  • 11.4 Hospital Pharmacy Historic and Forecast Sales by Regions
  • 11.5 Retail Pharmacy Historic and Forecast Sales by Regions
  • 11.6 Online Pharmacy Historic and Forecast Sales by Regions

12 . GLOBAL HERPES INFECTION TREATMENT MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE HERPES INFECTION TREATMENT COMPANIES

  • 13.1. Herpes Infection Treatment Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF HERPES INFECTION TREATMENT INDUSTRY

  • 14.1. Top  Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Teva Pharmaceutical Industries Ltd.
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. Abbott
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. GlaxoSmithKline plc
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. Cipla Inc.
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Eli Lilly and Company
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Merck & Co. Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. Novartis AG
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. F. Hoffmann-La Roche Ltd.
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Analysis by Product (USD MN)
  •  Therapeutics Market Sales by Geography (USD MN)
  •  Vaccine Market Sales by Geography (USD MN)
  •  Analysis Market by Type (USD MN)
  •  Herpes Simplex (Herpes Simplex 1, Herpes Simplex 2) Market Sales by Geography (USD MN)
  •  Herpes Zoster Market Sales by Geography (USD MN)
  •  Analysis by Drug (USD MN)
  •  Acyclovir Market Sales by Geography (USD MN)
  •  Valacyclovir Market Sales by Geography (USD MN)
  •  Famciclovir Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by Route Of Administration (USD MN)
  •  Oral Market Sales by Geography (USD MN)
  •  Topical Market Sales by Geography (USD MN)
  •  Injection Market Sales by Geography (USD MN)
  •  Analysis by Herpes Vaccine (USD MN)
  •  Herpes Simplex Market Sales by Geography (USD MN)
  •  Herpes Zoster Market Sales by Geography (USD MN)
  •  Analysis by Distribution Channel (USD MN)
  •  Hospital Pharmacy Market Sales by Geography (USD MN)
  •  Retail Pharmacy Market Sales by Geography (USD MN)
  •  Online Pharmacy Market Sales by Geography (USD MN)
  •  Global Herpes Infection Treatment Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton

LIST OF FIGURES

  •  Research Scope of Herpes Infection Treatment Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Herpes Infection Treatment Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Drug
  •  Market Attractiveness Analysis by Route Of Administration
  •  Market Attractiveness Analysis by Herpes Vaccine
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product (USD MN)
  •  Therapeutics Market Sales by Geography (USD MN)
  •  Vaccine Market Sales by Geography (USD MN)
  •  Global Market Analysis by Type (USD MN)
  •  Herpes Simplex (Herpes Simplex 1, Herpes Simplex 2) Market Sales by Geography (USD MN)
  •  Herpes Zoster Market Sales by Geography (USD MN)
  •  Global Market Analysis by Drug (USD MN)
  •  Acyclovir Market Sales by Geography (USD MN)
  •  Valacyclovir Market Sales by Geography (USD MN)
  •  Famciclovir Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Route Of Administration (USD MN)
  •  Oral Market Sales by Geography (USD MN)
  •  Topical Market Sales by Geography (USD MN)
  •  Injection Market Sales by Geography (USD MN)
  •  Global Market Analysis by Herpes Vaccine (USD MN)
  •  Herpes Simplex Market Sales by Geography (USD MN)
  •  Herpes Zoster Market Sales by Geography (USD MN)
  •  Global Market Analysis by Distribution Channel (USD MN)
  •  Hospital Pharmacy Market Sales by Geography (USD MN)
  •  Retail Pharmacy Market Sales by Geography (USD MN)
  •  Online Pharmacy Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top  Company Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.